Evommune Competitors and Similar CompaniesClear all
Evommune's competitors and similar companies include Athenex.
 Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2020 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Palo Alto, US HQ | |
Employees | Employees 4521% decrease | Employees 575 |
Financial | ||
Revenue (est.) | Revenue (est.) $13m (FY, 2025) | Revenue (est.) $102.8m (FY, 2022) |
Net income | Net income ($68.9m) (FY, 2025) | Net income ($104.4m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 57.5m | Total funding raised $ 252.1m |
For sources of this data, please see the company profile
View Company Profiles
Athenex
HQ
Buffalo, US
Employees
575
Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer.
View company